Long-Term Clinical Improvement in MPTP-Lesioned Primates after Gene Therapy with AAV-hAADC
Top Cited Papers
Open Access
- 31 October 2006
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 14 (4), 564-570
- https://doi.org/10.1016/j.ymthe.2006.05.005
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A Dose-Ranging Study of AAV-hAADC Therapy in Parkinsonian MonkeysMolecular Therapy, 2006
- Convection-Enhanced Delivery of Adeno-Associated Virus Type 2 (AAV2) into the Striatum and Transport of AAV2 Within Monkey BrainHuman Gene Therapy, 2006
- Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeysExperimental Neurology, 2006
- AAV2-mediated gene delivery to monkey putamen: Evaluation of an infusion device and delivery parametersExperimental Neurology, 2005
- Adeno‐associated virus‐mediated gene transfer of human aromatic l ‐amino acid decarboxylase protects mixed striatal primary cultures from l ‐DOPA toxicityJournal of Neurochemistry, 2005
- Rapid Uncoating of Vector Genomes Is the Key toEfficient Liver Transduction with Pseudotyped Adeno-Associated VirusVectorsJournal of Virology, 2004
- The Scientific Basis for the Current Treatment of Parkinson's DiseaseAnnual Review of Medicine, 2004
- Synaptic organization of the striatumJournal of Electron Microscopy Technique, 1988
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. GeneralizationsJournal of Cerebral Blood Flow & Metabolism, 1985